Taken together, results of this study indicate that the genetic ablation of the Nlrp2 gene delays the onset of kidney disease in Ctns-/- mice by reducing inflammatory infiltration, interstitial fibrosis, tubular lesions and apoptosis. This evidence concerns the gene NLRP2 and kidney disorder.